Compounds > ibogaine
Page last updated: 2024-09-05

ibogaine and buprenorphine

ibogaine has been researched along with buprenorphine in 3 studies

Compound Research Comparison

Studies
(ibogaine)		Trials
(ibogaine)		Recent Studies (post-2010)
(ibogaine)		Studies
(buprenorphine)		Trials
(buprenorphine)		Recent Studies (post-2010) (buprenorphine)
44581367,2731,2233,826

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP1
Chevillard, L; Declèves, X; Megarbane, B; Pirnay, S; Scherrmann, JM; Tournier, N1
Willyard, C1

Other Studies

3 other study(ies) available for ibogaine and buprenorphine

ArticleYear
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Journal of substance abuse treatment, 2007, Volume: 32, Issue:2

    Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome

2007
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:7

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Buprenorphine; Cell Line, Tumor; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Ibogaine; Illicit Drugs; Neoplasm Proteins

2010
Pharmacotherapy: Quest for the quitting pill.
    Nature, 2015, Jun-25, Volume: 522, Issue:7557

    Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins

2015